0604443 - ÚMG 2025 RIV NL eng J - Journal Article
Dolníková, A. - Kazantsev, D. - Klánová, M. - Pokorná, E. - Sovilj, D. - Kelemen, C.D. - Tuskova, L. - Hoferkova, E. - Mráz, M. - Helman, K. - Curik, N. - Poláková, K. M. - Anděra, Ladislav - Trněný, M. - Klener, P.
Blockage of BCL-XL overcomes venetoclax resistance across BCL2+lymphoid malignancies irrespective of BIM status.
Blood Advances. Roč. 8, č. 13 (2024), s. 3532-3543. ISSN 2473-9529. E-ISSN 2473-9537
R&D Projects: GA MŠMT LX22NPO5102
Institutional support: RVO:68378050
Keywords : chronic lymphocytic-leukemia * mantle cell lymphoma * homozygous deletions * susceptibility * sensitivity * ibrutinib * mcl-1
OECD category: Cell biology
Impact factor: 7.4, year: 2023 ; AIS: 2.996, rok: 2023
Method of publishing: Open access
Result website:
https://ashpublications.org/bloodadvances/article/8/13/3532/516030/Blockage-of-BCL-XL-overcomes-venetoclax-resistanceDOI: https://doi.org/10.1182/bloodadvances.2024012906
Permanent Link: https://hdl.handle.net/11104/0361840